The global Bacillus coagulans Market Growth Accelerated by Promising Health Benefits

Comments · 4 Views

Bacillus coagulans is a probiotic bacteria found in the human gastrointestinal tract. It can withstand high acidity in the stomach and helps promote a balanced microbiome in the intestines. Bacillus coagulans based probiotic supplements are gaining popularity for maintaining digestive health and immunity. The spores allow the probiotic to survive the manufacturing processes and endure stomach acid, so that large numbers of live bacteria can reach the intestines where they provide benefits.

 

The global Bacillus Coagulans Market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

 

Market Opportunity:

 

The opportunity to improve gut health is driving the Bacillus Coagulans market. A healthy gut microbiome is essential for overall well-being. However, modern lifestyles and diets have disrupted the gut bacteria balance. Consuming Bacillus Coagulans supplements helps restore the natural balance by populating the intestines with beneficial bacteria. This improves digestion, nutrient absorption and boosts immunity. Several clinical studies have demonstrated Bacillus Coagulans' role in alleviating abdominal discomfort, constipation, diarrhea and irritable bowel syndrome. Its enduring spore form allows the probiotic to benefit gut health over extended period of consumption. The growth in demand for natural remedies to support gut function is propelling the Bacillus Coagulans market expansion.

 

Porter's Analysis

 

Threat of new entrants: Low economies of scale in production and well established brands pose barriers for new companies.

 

Bargaining power of buyers: Buyers have moderate control since there are multiple suppliers in the market offering similar products.

 

Bargaining power of suppliers: Suppliers have low to moderate bargaining power as there are multiple alternative suppliers for raw materials used for production.

 

Threat of new substitutes: Limited threat as this probiotic strain has a proven ability for supporting digestive and intestinal health.

 

Competitive rivalry: High as the key companies compete on pricing and new product development to gain market share.

 

SWOT Analysis

 

Strengths: Unique health benefits and clinically demonstrated safety. Proven ability to survive manufacturing and shelf life.

 

Weaknesses: Require large capital investment for R&D and clinical trials. Limited consumer awareness about its health benefits.

 

Opportunities: Growing demand from food and dietary supplement segments. Potential to explore new therapeutic areas and geographical expansion.

 

Threats: Stringent regulations for new strains and product approvals. Intense competition from other popular probiotic strains.

 

Key Takeaways

 

The Global Bacillus Coagulans Market Size is expected to witness high growth over the forecast period driven by increasing consumers focus on gut and digestive health. The global Bacillus coagulans Market is estimated to be valued at US$ 722.43 Mn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030

North America currently dominates the market owing to rising health consciousness and growing use of probiotic dietary supplements for promoting intestinal wellness. The Asia Pacific region is expected to be the fastest growing market in the coming years fueled by growth in the functional food and nutrition industry in countries like India, China and Japan.

 

Key players operating in the Bacillus Coagulans market are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech. These players are focusing on expansions, new product launches, and partnerships to strengthen their distribution network and market presence. The market is also witnessing emergence of several private label brands. However, Ganeden and Sabinsa Corporation hold major shares of the global market due to their well established brand names and distribution channels across key regions.
Get More Insights Here

https://www.newswirestats.com/bacillus-coagulans-market/

disclaimer
Read more
Comments